Cargando…
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection is a recently emerged viral infection causing predominantly mild upper respiratory symptoms. However, in some instances, it might result in acute respiratory distress syndrome (ARDS) that poses a significant mortality...
Autores principales: | Elshafei, Mohamed Nabil, Khalil, Ahmed, El-Bardissy, Ahmed, Danjuma, Mohammed, Ahmed, Mohamed Badie, Mohamed, Mouhand F.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478773/ https://www.ncbi.nlm.nih.gov/pubmed/32899023 http://dx.doi.org/10.1097/MD.0000000000021911 |
Ejemplares similares
-
Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021) -
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021) -
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
por: Danjuma, Mohammed I., et al.
Publicado: (2023) -
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)